Entrada Therapeutics has appointed Linea Aspesi as its new Chief People Officer. Aspesi brings over 20 years of experience in organizational leadership and culture transformation in biopharmaceutical companies. Her role will focus on scaling the company's workforce and fostering a strong, mission-driven culture as Entrada advances its genetic medicine pipeline, particularly for neuromuscular diseases. This leadership addition aims to strengthen the company's team during a critical growth phase.
Entrada Therapeutics appointing Linea Aspesi as Chief People Officer comes as a backdrop to a mixed health sector on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 21, 2026 18:11 WIB: out of 150 priced US health-sector stocks, 71 rose and 67 fell. Notable movers include TWST at USD 137.09 with a 3.93% decline and 100% buy order activity, TNGX at USD 26.20 up 3.76%, and BAX at USD 25.30 up 3.22% with balanced buy/sell activity.
The Human Feedback Foundation, supported by RBC, has launched the Agentic AI Design Exchange, a national program aimed at helping Canadian nonprofits design, build, and deploy AI agents responsibly. Funded through RBC's Stronger Nonprofits Program, t...
Satellos Bioscience Inc., a clinical-stage company focused on treatments for degenerative muscle diseases, announced its management will participate in two investor conferences in November: the Guggenheim Healthcare Innovation Conference on Nov 9 in ...
YYForce Inc. has purchased 20 wearable data collection systems to gather real task data from hotel room service at Novotel Singapore. This project aims to record and analyze experienced staff performing tasks like bed-making, towel folding, and clean...
The global digital health and remote patient monitoring market is projected to grow from $26.8 billion in 2025 to $80.8 billion by 2031, at a compound annual growth rate of 20.2%. This growth is driven by increasing demand for chronic disease managem...
The global private credit and alternative lending market, valued at $2.31 trillion in 2026, is expected to grow at a 7.8% CAGR to reach $3.36 trillion by 2031. Recent liquidity pressures in 2025, triggered by bankruptcies and AI sector concerns, caus...
